Citations (114)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (20)
Fawaz Albloui, James John, Osama Alghamdi, Faisal Alseraye, Abdullah Alqahtani, Waleed Tamimi, Abdullah Albloshi, Fahad M. Aldakheel, Ayesha Mateen & Rabbani Syed. (2022) Effect of hematocrit, galactose and ascorbic acid on the blood glucose readings of three point-of-care glucometers. Scandinavian Journal of Clinical and Laboratory Investigation 82:7-8, pages 563-570.
Read now
Read now
Hirotaka Watada, Toshimasa Yamauchi, Fumiko Yamamoto, Atsushi Taniguchi, Larisa Yarush, Clemens Heilmann & Atsutaka Yasui. (2020) Safety and tolerability of empagliflozin and linagliptin combination therapy in patients with type 2 diabetes mellitus: a pooled analysis of data from five randomized, controlled clinical trials. Expert Opinion on Drug Safety 19:9, pages 1193-1202.
Read now
Read now
Nick Freemantle, Didac Mauricio, Andrea Giaccari, Timothy Bailey, Ronan Roussel, Denise Franco, Baptiste Berthou, Valerie Pilorget, Jukka Westerbacka, Zsolt Bosnyak, Mireille Bonnemaire, Anna M. G. Cali, My-Liên Nguyên-Pascal, Alfred Penfornis, Manuel Perez-Maraver, Jochen Seufert, Sean D. Sullivan, John Wilding, Carol Wysham & Melanie Davies. (2020) Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus. Current Medical Research and Opinion 36:4, pages 571-581.
Read now
Read now
Toshinari Asakura, Shuichi Suzuki, Toshihiko Aranishi & Zhihong Cai. (2018) Comparative usability study of the dulaglutide single-use pen versus the insulin degludec FlexTouch® among self-injection-naïve patients with type 2 diabetes mellitus in Japan. Current Medical Research and Opinion 34:6, pages 1117-1124.
Read now
Read now
Eric L. Johnson, Juan P. Frias & Jennifer M. Trujillo. (2018) Anticipatory guidance in type 2 diabetes to improve disease management; next steps after basal insulin. Postgraduate Medicine 130:4, pages 365-374.
Read now
Read now
Wing Bun Chan, Jung Fu Chen, Su-Yen Goh, Thi Thanh Huyen Vu, Iris Thiele Isip-Tan, Sony Wibisono Mudjanarko, Shailendra Bajpai, Maria Aileen Mabunay & Pongamorn Bunnag. (2017) Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience. Diabetes, Metabolic Syndrome and Obesity 10, pages 521-532.
Read now
Read now
Takashi Kadowaki, Kazuoki Kondo, Noriyuki Sasaki, Kyoko Miyayama, Shoko Yokota, Ryuji Terata & Maki Gouda. (2017) Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period. Expert Opinion on Pharmacotherapy 18:13, pages 1291-1300.
Read now
Read now
Jodi Strong, Davida Kruger & Lucia Novak. (2017) Insulin glargine 300 units/mL: a guide for healthcare professionals involved in the management of diabetes. Current Medical Research and Opinion 33:4, pages 785-793.
Read now
Read now
Kristina Secnik Boye, Sarah E Curtis, Maureen J Lage & Luis-Emilio Garcia-Perez. (2016) Associations between adherence and outcomes among older, type 2 diabetes patients: evidence from a Medicare Supplemental database. Patient Preference and Adherence 10, pages 1573-1581.
Read now
Read now
Michał Jakubczyk, Izabela Lipka, Justyna Pawęska, Maciej Niewada, Elżbieta Rdzanek, Jelka Zaletel, Antonio Ramírez de Arellano, Tomáš Doležal, Biljana Chekorova Mitreva, Bence Nagy, Guenka Petrova, Tereza Šarić, John Yfantopoulos & Marcin Czech. (2016) Cost of severe hypoglycaemia in nine European countries. Journal of Medical Economics 19:10, pages 973-982.
Read now
Read now
Louise Watson, Romita Das, Ruth Farquhar, Haya Langerman & Anthony H. Barnett. (2016) Consequences of delaying treatment intensification in type 2 diabetes: evidence from a UK database. Current Medical Research and Opinion 32:9, pages 1465-1475.
Read now
Read now
Daisuke Yabe & Yutaka Seino. (2016) Alogliptin for the treatment of type 2 diabetes: a drug safety evaluation. Expert Opinion on Drug Safety 15:2, pages 249-264.
Read now
Read now
Elizabeth L Eby, Kate Van Brunt, Cynthia Brusko, Bradley Curtis & Maureen J Lage. (2015) Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetes. Clinical Interventions in Aging 10, pages 991-1001.
Read now
Read now
Iskandar Idris, Jason Gordon, Carl Tilling & Jiten Vora. (2015) A cost comparison of long-acting insulin analogs vs NPH insulin-based treatment in patients with type 2 diabetes using routinely collected primary care data from the UK. Journal of Medical Economics 18:4, pages 273-282.
Read now
Read now
André J Scheen. (2015) Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes. Expert Opinion on Drug Safety 14:4, pages 505-524.
Read now
Read now
André J Scheen. (2015) A review of gliptins for 2014. Expert Opinion on Pharmacotherapy 16:1, pages 43-62.
Read now
Read now
Anja Schweizer, Serge Halimi & Sylvie Dejager. (2014) Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan. Vascular Health and Risk Management 10, pages 15-24.
Read now
Read now
John B. Buse, Jenny Han, Stephan Miller, Leigh MacConell, Richard Pencek & Matthew Wintle. (2014) Addition of exenatide BID to insulin glargine: a post-hoc analysis of the effect on glycemia and weight across a range of insulin titration. Current Medical Research and Opinion 30:7, pages 1209-1218.
Read now
Read now
Karoline von Websky, Christoph Reichetzeder & Berthold Hocher. (2013) Linagliptin as add-on therapy to insulin for patients with type 2 diabetes. Vascular Health and Risk Management 9, pages 681-694.
Read now
Read now
Lin Xie, Wenhui Wei, Chunshen Pan & Onur Baser. (2013) Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies. Journal of Medical Economics 16:9, pages 1137-1145.
Read now
Read now
Articles from other publishers (94)
Chung-Yi Li, Chia-Lun Kuo, Ya-Hui Chang, Chin-Li Lu, Santi Martini & Wen-Hsuan Hou. (2022) Association Between Trajectory of Severe Hypoglycemia and Dementia in Patients With Type 2 Diabetes: A Population-based Study. Journal of Epidemiology 32:9, pages 423-430.
Crossref
Crossref
Christian Göbl, Micaela Morettini, Benedetta Salvatori, Wathik Alsalim, Hana Kahleova, Bo Ahrén & Andrea Tura. (2022) Temporal Patterns of Glucagon and Its Relationships with Glucose and Insulin following Ingestion of Different Classes of Macronutrients. Nutrients 14:2, pages 376.
Crossref
Crossref
Sílvia Alão, João Conceição, Jorge Dores, Lèlita Santos, Francisco Araújo, Estevão Pape, Mónica Reis, Árcia Chipepo, Edite Nascimento, Ana Baptista, Vanessa Pires, Carlos Marques, Adriana De Sousa Lages, João Pelicano-Romano & Paula M. de Jesus. (2021) Hypoglycemic episodes in hospitalized people with diabetes in Portugal: the HIPOS-WARD study. Clinical Diabetes and Endocrinology 7:1.
Crossref
Crossref
Sake Juli Martina, Aznan Lelo, Dharma Lindarto, Ratna Akbari Ganie, Muhammad Ichwan, Hanifah Yusuf, Syafruddin Ilyas & Iqbal Pahlevi Nasution. (2021) The Effect of Coffee Arabica Gayo Leaf Extract (Coffea arabica L.) in Increasing Phosphoinositide 3-kinase and Glucose Transporter-4 Expression in the Skeletal Muscle. Open Access Macedonian Journal of Medical Sciences 9:A, pages 906-910.
Crossref
Crossref
Tatiana Valente & Alberto K. Arbex. (2021) Glycemic Variability, Oxidative Stress, and Impact on Complications Related to Type 2 Diabetes Mellitus. Current Diabetes Reviews 17:7.
Crossref
Crossref
Subhash Wangnoo, M. Shunmugavelu, Sagili Vijaya Bhaskar Reddy, Vijay Negalur, Shreerang Godbole, Vinay K Dhandhania, Nareen Krishna & Kumar Gaurav. (2021) Role of Gliclazide in safely navigating type 2 diabetes mellitus patients towards euglycemia: Expert opinion from India. Endocrine and Metabolic Science 4, pages 100102.
Crossref
Crossref
David A. Bradley & Phil A. Hart. 2021. Clinical Pancreatology for Practising Gastroenterologists and Surgeons. Clinical Pancreatology for Practising Gastroenterologists and Surgeons
668
678
.
Sake Juli Martina, Aznan Lelo, Dharma Lindarto, Ratna Akbari Ganie, Muhammad Ichwan, Hanifah Yusuf, Syafruddin Ilyas & Iqbal Pahlevi Nasution. (2021) The Decreasing of Homeostatic Model Assessment – Insulin Resistance Levels after Given Coffee Arabica Gayo Leaf Extract (Coffea arabica L.) to Type 2 Diabetes Mellitus Rats. Open Access Macedonian Journal of Medical Sciences 9:A, pages 356-361.
Crossref
Crossref
Anders L. Carlson, Lauren M. Huyett, Jay Jantz, Albert Chang, Todd Vienneau & Trang T. Ly. (2021) Improved glycemic control in 3,592 adults with type 2 diabetes mellitus initiating a tubeless insulin management system. Diabetes Research and Clinical Practice 174, pages 108735.
Crossref
Crossref
Zdravko Kamenov, Veselina Pehlivanova, Tsvetodara Kuneva, Kiril Kirilov, Roza Bobeva, Julija Stoykova & Svetla Mihalevska. (2021) Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Patients with T2D Uncontrolled on NPH or Premixed Insulins as Part of Routine Clinical Practice in Bulgaria: ToUPGRADE Study. Diabetes Therapy 12:3, pages 913-930.
Crossref
Crossref
Mark A. Espeland, Richard E. Pratley, Julio Rosenstock, Takashi Kadowaki, Yutaka Seino, Bernard Zinman, Nikolaus Marx, Darren K. McGuire, Knut Robert Andersen, Michaela Mattheus, Annett Keller, Maria Weber & Odd Erik Johansen. (2020)
Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized
CAROLINA
trial
. Diabetes, Obesity and Metabolism 23:2, pages 569-580.
Crossref
Crossref
Ahmed Elshebiny, Hassan Alali, Zainab Alamer, Yasmin Alsultan, Hashim Alkhalaf, Abdullah Alkishi & Mohammed Alsuwaylih. (2021) The incidence of hypoglycemia and its risk factors among diabetic patients in the Eastern Province of Saudi Arabia. International Journal of Medicine in Developing Countries, pages 614-621.
Crossref
Crossref
Amme Mardulate Tshabalala, Adedayo Tunde Ajidahun, Treginah Mkhabela, Phemelo Bapela, Constance Majumane & Tshepo Msimango. (2021) Prevalence and factors associated with fear of hypoglycaemia among adults with Type 1 diabetes mellitus at an academic hospital in South Africa. International Journal of Africa Nursing Sciences 15, pages 100367.
Crossref
Crossref
Takashi Kadowaki, Guang Wang, Julio Rosenstock, Daisuke Yabe, Yongde Peng, Keizo Kanasaki, Yiming Mu, Michaela Mattheus, Annett Keller, Tomoo Okamura, Odd Erik Johansen & Nikolaus Marx. (2020) Effect of linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulfonylurea glimepiride on cardiovascular outcomes in Asians with type 2 diabetes: subgroup analysis of the randomized CAROLINA® trial. Diabetology International 12:1, pages 87-100.
Crossref
Crossref
Thomas Semlitsch, Jennifer Engler, Andrea Siebenhofer, Klaus Jeitler, Andrea Berghold & Karl Horvath. (2020) (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2020:11.
Crossref
Crossref
Federica Ferrari, Antonio Moretti & Roberto Federico Villa. (2020) The treament of hyperglycemia in acute ischemic stroke with incretin-based drugs. Pharmacological Research 160, pages 105018.
Crossref
Crossref
Wolfgang Rathmann, Bernard Charbonnel, Marília B. Gomes, Niklas Hammar, Kamlesh Khunti, Mikhail Kosiborod, Oliver Kuss, Marina V. Shestakova, Hirotaka Watada, Iichiro Shimomura, Fengming Tang, Javier Cid-Ruzafa, Hungta Chen, Peter Fenici, Filip Surmont & Linong Ji. (2020) Socioeconomic factors associated with hypoglycaemia in patients starting second-line glucose-lowering therapy: The DISCOVER study. Diabetes Research and Clinical Practice 165, pages 108250.
Crossref
Crossref
Sujoy Ghosh & Romik Ghosh. (2020) Glargine-300: An updated literature review on randomized controlled trials and real-world studies. World Journal of Diabetes 11:4, pages 100-114.
Crossref
Crossref
NC Tan, S Goh, EY Khoo, R Dalan, A Koong, CM, Khoo, TS Tan, AB Jain, AV Gadekar & YM Bee. (2020) Self-reported hypoglycaemia in insulin-treated patients with diabetes mellitus: results from the Singapore cohort of the International Operations Hypoglycaemia Assessment Tool study. Singapore Medical Journal 61:3, pages 129-136.
Crossref
Crossref
Koji Nakashima, Nobuhiro Okamura, Hayato Sanefuji & Hideaki Kaneto. (2020) Practical application of short-term intensive insulin therapy based on the concept of “treat to target” to reduce hypoglycaemia in routine clinical site. Scientific Reports 10:1.
Crossref
Crossref
Young-Hoon Lee. (2020) Sociodemographic Factors Associated with Participation in Diabetes Education among Community-Dwelling Adults with Diabetes. Yonsei Medical Journal 61:2, pages 169.
Crossref
Crossref
Stavros Liatis, Styliani Iraklianou, Kyriakos Kazakos, George Mastorakos, Kostas Milios, Zadalla Mouslech, Marina Noutsou, Emmanouil Pagkalos & Christos Sampanis. (2019) A Greek registry of current type 2 diabetes management, aiming to determine core clinical approaches, patterns and strategies. BMC Endocrine Disorders 19:1.
Crossref
Crossref
Gashayeneh Genetu Tiruneh, Nurilign Abebe & Getenet Dessie. (2019) Self-reported hypoglycemia in adult diabetic patients in East Gojjam, Northwest Ethiopia: institution based cross-sectional study. BMC Endocrine Disorders 19:1.
Crossref
Crossref
Pengxiang Li, Zhi Geng, Vrushabh P. Ladage, Jasmanda Wu, Ilona Lorincz & Jalpa A. Doshi. (2019) Early hypoglycaemia and adherence after basal insulin initiation in a nationally representative sample of Medicare beneficiaries with type 2 diabetes. Diabetes, Obesity and Metabolism 21:11, pages 2486-2495.
Crossref
Crossref
Johan Farngren & Bo Ahrén. (2019) Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes. Metabolism 99, pages 25-31.
Crossref
Crossref
Amanda K. Kitten, Meghan Kamath, Laurajo Ryan & Kelly R. Reveles. (2019) National ambulatory care non-insulin antidiabetic medication prescribing trends in the United States from 2009 to 2015. PLOS ONE 14:8, pages e0221174.
Crossref
Crossref
Noor Syaffinaz Noor Mohamad Zin, Nooraain Hashim, Nurdiana Samsulrizal & Nur Syimal'ain Azmi. (2019) The protective effect of Azadirachta excelsa leaves extract and quercetin treatment on the learning and memory impairments in relation with insulin and amylin levels in the brain of streptozotocin-induced diabetic rats. Journal of King Saud University - Science 31:3, pages 299-307.
Crossref
Crossref
Fang L. Zhou, Charlie Nicholls, Lin Xie, Yuexi Wang, Neel Vaidya & Luigi F. Meneghini. (2019) Hypoglycaemia and treatment patterns among insulin‐treated patients with type 2 diabetes who switched to insulin glargine 300 units/mL versus other basal insulin in a real‐world setting. Endocrinology, Diabetes & Metabolism 2:3.
Crossref
Crossref
Luigi F. Meneghini, Didac Mauricio, Emanuela Orsi, Nebojsa M. Lalic, Anna M.G. Cali, Jukka Westerbacka, Peter Stella, Christophe Candelas, DEA, Valerie Pilorget, Riccardo Perfetti & Kamlesh Khunti. (2019) The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real‐world setting. Diabetes, Obesity and Metabolism 21:6, pages 1429-1436.
Crossref
Crossref
Juan Pablo Maianti, Grace A. Tan, Amedeo Vetere, Amie J. Welsh, Bridget K. Wagner, Markus A. Seeliger & David R. Liu. (2019) Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme. Nature Chemical Biology 15:6, pages 565-574.
Crossref
Crossref
Hareld Kemps, Nicolle Kränkel, Marcus Dörr, Trine Moholdt, Matthias Wilhelm, Francesco Paneni, Luis Serratosa, Erik Ekker Solberg, Dominique Hansen, Martin Halle & Marco Guazzi. (2019) Exercise training for patients with type 2 diabetes and cardiovascular disease: What to pursue and how to do it. A Position Paper of the European Association of Preventive Cardiology (EAPC). European Journal of Preventive Cardiology 26:7, pages 709-727.
Crossref
Crossref
Kai‐Jen Tien, Yi‐Jen Hung, Jung‐Fu Chen, Ching‐Chu Chen, Chih‐Yuan Wang, Chii‐Min Hwu, Yu‐Yao Huang, Pi‐Jung Hsiao, Shih‐Te Tu, Chao‐Hung Wang & Wayne Huey‐Herng Sheu. (2019) Basal insulin therapy: Unmet medical needs in Asia and the new insulin glargine in diabetes treatment. Journal of Diabetes Investigation 10:3, pages 560-570.
Crossref
Crossref
Alena Strizek, Chee-Jen Chang, Wesley Furnback, Bruce Wang, Jérémie Lebrec & Thomas Lew. (2019) The Cost of Hypoglycemia Associated With Type 2 Diabetes Mellitus in Taiwan. Value in Health Regional Issues 18, pages 84-90.
Crossref
Crossref
Bo Ahrén. (2019) Glucagon-like peptide-1 receptor agonists for type 2 diabetes: A rational drug development. Journal of Diabetes Investigation 10:2, pages 196-201.
Crossref
Crossref
Tricia Santos Cavaiola, Yan Kiriakov & Timothy Reid. (2019) Primary Care Management of Patients With Type 2 Diabetes: Overcoming Inertia and Advancing Therapy With the Use of Injectables. Clinical Therapeutics 41:2, pages 352-367.
Crossref
Crossref
Marius Nistor, Martin Schmidt, Isabel Graul, Florian Rakers & René Schiffner. (2019) A Systematic Review of Neuroprotective Strategies in the Management of Hypoglycemia. International Journal of Molecular Sciences 20:3, pages 550.
Crossref
Crossref
Jing-Xia Kong, Lin Zhu, Hong-Mei Wang, Ying Li, An-Ying Guo, Chao Gao, Yan-Yao Miao, Ting Wang, Xiao-Yang Lu, Hong-Hong Zhu & Donald L. Patrick. (2019) Effectiveness of the Chronic Care Model in Type 2 Diabetes Management in a Community Health Service Center in China: A Group Randomized Experimental Study. Journal of Diabetes Research 2019, pages 1-12.
Crossref
Crossref
Ayla M. Tourkmani, Turki J. Alharbi, Abdulaziz M. Bin Rsheed, Abdulrhamn N. AlRasheed, Saad M. AlBattal, Osama Abdelhay, Mohamed A. Hassali, Sultan I. Faya, Ebrahim S. Assiri, Khalid I. Al Ghishiayan, Alian A. Alrasheedy & Mostafa AF. Abbas. (2019) Impact of Ramadan Focused Education Program on medications adjustment for patients with type 2 diabetes in a primary health care institution in Saudi Arabia. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13:1, pages 161-165.
Crossref
Crossref
H. A. Dissanayake, G. S. P. Keerthisena, K. K. K. Gamage, J. H. Liyanage, I. R. H. S. Ihalagama, W. M. U. A. Wijetunga, T. A. D. Tillekaratne, G. W. Katulanda & P. Katulanda. (2018) Hypoglycaemia in diabetes: do we think enough of the cause? An observational study on prevalence and causes of hypoglycaemia among patients with type 2 diabetes in an out-patient setting in Sri Lanka. BMC Endocrine Disorders 18:1.
Crossref
Crossref
David Nathanson, Ugne Sabale, Jan W. Eriksson, Thomas Nyström, Anna Norhammar, Urban Olsson & Johan Bodegård. (2017) Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006–2014. PharmacoEconomics - Open 2:4, pages 393-402.
Crossref
Crossref
Tomoya Ikeda, Naoto Tani, Shigeki Oritani, Alissa Shida, Yayoi Aoki, Fumiya Morioka & Takaki Ishikawa. (2018) Toxicological and Biochemical Analyses of an Autopsy Case Involving Oral Overdose of Multiple Antidiabetic and Antihypertensive Drugs. Case Reports in Medicine 2018, pages 1-8.
Crossref
Crossref
Jennifer Okemah, John Peng & Manuel Quiñones. (2018) Addressing Clinical Inertia in Type 2 Diabetes Mellitus: A Review. Advances in Therapy 35:11, pages 1735-1745.
Crossref
Crossref
Masahiko Gosho. (2018) Risk of Hypoglycemia After Concomitant Use of Antidiabetic, Antihypertensive, and Antihyperlipidemic Medications: A Database Study. The Journal of Clinical Pharmacology 58:10, pages 1324-1331.
Crossref
Crossref
Ayla M. Tourkmani, Turki J. Alharbi, Abdulaziz M. Bin Rsheed, Abdulrhamn N. AlRasheed, Saad M. AlBattal, Osama Abdelhay, Mohamed A. Hassali, Alian A. Alrasheedy, Nouf G. Al Harbi & Abdulaziz Alqahtani. (2018) Hypoglycemia in Type 2 Diabetes Mellitus patients: A review article. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12:5, pages 791-794.
Crossref
Crossref
Johan Farngren, Margaretha Persson & Bo Ahrén. (2018) Effects on the glucagon response to hypoglycaemia during DPP-4 inhibition in elderly subjects with type 2 diabetes: A randomized, placebo-controlled study. Diabetes, Obesity and Metabolism 20:8, pages 1911-1920.
Crossref
Crossref
A. V. Petrov & L. G. Strongin. (2018) Hypoglycemia after initiating insulin therapy based on the results of structured self-control and monitoring of blood glucose. Medical Council:12, pages 112-116.
Crossref
Crossref
Simon J. Fisher, Xingyue Huang, Manjiri Pawaskar, Edward A. Witt, Swapnil Rajpathak, R. Ravi Shankar & Silvio E. Inzucchi. (2018) Hypoglycemia in type 2 diabetes: understanding patients’ and physicians’ knowledge and experience. Endocrine 60:3, pages 435-444.
Crossref
Crossref
Manjiri Pawaskar, Kristy Iglay, Edward A. Witt, Samuel S. Engel & Swapnil Rajpathak. (2018) Impact of the severity of hypoglycemia on health - Related quality of life, productivity, resource use, and costs among US patients with type 2 diabetes. Journal of Diabetes and its Complications 32:5, pages 451-457.
Crossref
Crossref
Manjiri Pawaskar, Edward A. Witt, Samuel S. Engel, Swapnil N. Rajpathak & Kristy Iglay. (2018) Severity of hypoglycaemia and health-related quality of life, work productivity and healthcare costs in patients with type 2 diabetes in Europe. Endocrinology, Diabetes & Metabolism 1:2, pages e00011.
Crossref
Crossref
Guillermo E. Umpierrez, Timothy S. Bailey, Danielle Carcia, Charles Shaefer, Jay H. Shubrook & Neil Skolnik. (2018) Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies. Journal of Diabetes 10:2, pages 94-111.
Crossref
Crossref
João Conceição, Jorge Dores, Francisco Araújo, Pedro A. Laires, Richard D. Carr, Kimberly Brodovicz, Larry Radican & Ana M. Nogueira. (2017)
Severe hypoglycaemia among patients with type 2 diabetes requiring emergency hospital admission:
T
he
H
ypoglycaemia
I
n
P
ortugal
O
bservational
S
tudy–
E
mergency
R
oom (
HIPOS
–
ER
)
. Diabetes, Obesity and Metabolism 20:1, pages 50-59.
Crossref
Crossref
Freddy G. Eliaschewitz, Mauricio A. de Paula, Hermelinda C. Pedrosa, Antônio Carlos Pires, João Eduardo N. Salles, Marcos Antônio Tambascia & Luiz Alberto A. Turatti. (2018) Barriers to insulin initiation in elderly patients with type 2 diabetes mellitus in Brazil. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12:1, pages 39-44.
Crossref
Crossref
Sandra L. Jackson, Lisa R. Staimez, Sandra Safo, Qi Long, Mary K. Rhee, Solveig A. Cunningham, Darin E. Olson, Anne M. Tomolo, Usha Ramakrishnan, Venkat K.M. Narayan & Lawrence S. Phillips. (2017) Participation in a National Lifestyle Change Program is associated with improved diabetes Control outcomes. Journal of Diabetes and its Complications 31:9, pages 1430-1436.
Crossref
Crossref
David C. Klonoff, G. Alexander Fleming, Douglas B. Muchmore & Brian M. Frier. (2017) Hypoglycemia evaluation and reporting in diabetes: Importance for the development of new therapies. Diabetes/Metabolism Research and Reviews 33:5, pages e2883.
Crossref
Crossref
Lyudmila Alexandrovna Ruyatkina & Maxim Sorokin. (2017) Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance. Diabetes mellitus 20:2, pages 142-150.
Crossref
Crossref
Michael J. Toohey & Raymond DiGiuseppe. (2017) Defining and measuring irritability: Construct clarification and differentiation. Clinical Psychology Review 53, pages 93-108.
Crossref
Crossref
Qing Qiao, Kristina Johnsson, Susan Grandy & Karel Kostev. (2016) Treatment Outcomes and Tolerability Following Initiation of GLP-1 Receptor Agonists Among Type 2 Diabetes Patients in Primary Care Practices in Germany. Journal of Diabetes Science and Technology 11:2, pages 272-277.
Crossref
Crossref
Eirik Søfteland, Juris J. Meier, Bente Vangen, Robert ToorawaMario Maldonado-Lutomirsky & Uli C. Broedl. (2017) Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial. Diabetes Care 40:2, pages 201-209.
Crossref
Crossref
Francisco J. Tinahones, Baptist Gallwitz, Matias Nordaby, Sophia Götz, Mario Maldonado-Lutomirsky, Hans J. Woerle & Uli C. Broedl. (2017) Linagliptin as add-on to empagliflozin and metformin in patients with type 2 diabetes: Two 24-week randomized, double-blind, double-dummy, parallel-group trials. Diabetes, Obesity and Metabolism 19:2, pages 266-274.
Crossref
Crossref
Pia V. Röder, Xiuming Wong, Wanjin Hong & Weiping Han. (2016) Molecular regulation of insulin granule biogenesis and exocytosis. Biochemical Journal 473:18, pages 2737-2756.
Crossref
Crossref
Julio A. Rebolledo & Regina Arellano. (2016) Cultural Differences and Considerations When Initiating Insulin. Diabetes Spectrum 29:3, pages 185-190.
Crossref
Crossref
Adriana Coppola, Loredana Sasso, Annamaria Bagnasco, Andrea Giustina & Carmine Gazzaruso. (2015) The role of patient education in the prevention and management of type 2 diabetes: an overview. Endocrine 53:1, pages 18-27.
Crossref
Crossref
Shiva Mansouri, Grazyna Lietzau, Mathias Lundberg, David Nathanson, Thomas Nyström & Cesare Patrone. (2016) Pituitary Adenlylate Cyclase Activating Peptide Protects Adult Neural Stem Cells from a Hypoglycaemic milieu. PLOS ONE 11:6, pages e0156867.
Crossref
Crossref
Changyu Pan, Jorge L. Gross, Wenying Yang, Xiaofeng Lv, Li Sun, Charlotte Thim Hansen, Hongfei Xu & Robert Wagner. (2016) A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus. Drugs in R&D 16:2, pages 239-249.
Crossref
Crossref
Pavika J Lyngsie, Sandra Lopes & Jens Olsen. (2016) Incidence and cost of hypoglycemic events requiring medical assistance in a hospital setting in Denmark. Journal of Comparative Effectiveness Research 5:3, pages 239-247.
Crossref
Crossref
Pia V Röder, Bingbing Wu, Yixian Liu & Weiping Han. (2016) Pancreatic regulation of glucose homeostasis. Experimental & Molecular Medicine 48:3, pages e219-e219.
Crossref
Crossref
Johan Farngren, Margaretha Persson & Bo Ahrén. (2016) Effect of the GLP-1 Receptor Agonist Lixisenatide on Counterregulatory Responses to Hypoglycemia in Subjects With Insulin-Treated Type 2 Diabetes. Diabetes Care 39:2, pages 242-249.
Crossref
Crossref
Siri Malmgren & Bo Ahrén. (2016) Evidence for time dependent variation of glucagon secretion in mice. Peptides 76, pages 102-107.
Crossref
Crossref
R. Sekar, K. Singh, A.W.R. Arokiaraj & B.K.C. Chow. 2016.
279
341
.
Ying-Ju Chen, Chen-Chang Yang, Lynn-Chu Huang, Likwang Chen & Chii-Min Hwu. (2015) Increasing trend in emergency department visits for hypoglycemia from patients with type 2 diabetes mellitus in Taiwan. Primary Care Diabetes 9:6, pages 490-496.
Crossref
Crossref
B. Ahrén. (2015) Physiological aspects of the combination of insulin and GLP-1 in the regulation of blood glucose control. Diabetes & Metabolism 41:6, pages 6S3-6S8.
Crossref
Crossref
Siri Malmgren & Bo Ahrén. (2015) Deciphering the Hypoglycemic Glucagon Response: Development of a Graded Hyperinsulinemic Hypoglycemic Clamp Technique in Female Mice. Endocrinology 156:10, pages 3866-3871.
Crossref
Crossref
Elizabeth L. Eby, Kate Van Brunt, Cynthia Brusko, Bradley Curtis & Maureen J. Lage. (2015) Insulin Dosing and Outcomes Among Commercially Insured Patients With Type 2 Diabetes in the United States. Clinical Therapeutics 37:10, pages 2297-2308.e1.
Crossref
Crossref
Janice M.S. LopezRobert A. BaileyMarcia F.T. Rupnow. (2015) Demographic Disparities Among Medicare Beneficiaries with Type 2 Diabetes Mellitus in 2011: Diabetes Prevalence, Comorbidities, and Hypoglycemia Events. Population Health Management 18:4, pages 283-289.
Crossref
Crossref
Bo Ahrén. (2015) Creative use of novel glucose-lowering drugs for type 2 diabetes: where will we head in the next 50 years?. Diabetologia 58:8, pages 1740-1744.
Crossref
Crossref
Yun Chen, Li Liu, Liqun Gu, Steven Babineaux, Hayley Colclough & Bradley Curtis. (2015) Glycemic Control in Chinese Patients with Type 2 Diabetes Mellitus Receiving Oral Antihyperglycemic Medication-Only or Insulin-Only Treatment: A Cross-Sectional Survey. Diabetes Therapy 6:2, pages 197-211.
Crossref
Crossref
Julia A. Carlson, Kay Craven & Kathryn Kolasa. (2015) Feeding Insulin. Nutrition Today 50:3, pages 109-116.
Crossref
Crossref
Bo Ahrén. (2015) Glucagon – Early breakthroughs and recent discoveries. Peptides 67, pages 74-81.
Crossref
Crossref
Siri Malmgren & Bo Ahrén. (2015) DPP-4 inhibition contributes to the prevention of hypoglycaemia through a GIP–glucagon counterregulatory axis in mice. Diabetologia 58:5, pages 1091-1099.
Crossref
Crossref
S. Halimi. (2015) Severe hypoglycaemia the “tip of the iceberg”: An underestimated risk in both type 1 and type 2 diabetic patients. Diabetes & Metabolism 41:2, pages 105-106.
Crossref
Crossref
Andrew Lewin, Ralph A. DeFronzo, Sanjay PatelDacheng Liu, Renee Kaste, Hans J. Woerle & Uli C. Broedl. (2015) Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes. Diabetes Care 38:3, pages 394-402.
Crossref
Crossref
Elke R. Fährmann, Laura Adkins, Cameron J. Loader, Hyoil Han, Kevin M. Rice, James Denvir & Henry K. Driscoll. (2015) Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study. Diabetes Research and Clinical Practice 107:2, pages 280-289.
Crossref
Crossref
Kyong Park. (2015) Trends in adherence to dietary recommendations among Korean type 2 diabetes mellitus patients. Nutrition Research and Practice 9:6, pages 658.
Crossref
Crossref
Saul Genuth. (2015) Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? No, It’s Time to Move On!. Diabetes Care 38:1, pages 170-175.
Crossref
Crossref
Francesco Paneni & Francesco CosentinoFrancesco Paneni & Francesco Cosentino. 2015. Diabetes and Cardiovascular Disease. Diabetes and Cardiovascular Disease
85
100
.
G. Schernthaner, A. H. Barnett, S. Patel, U. Hehnke, M. von Eynatten & H.-J. Woerle. (2014) Safety and efficacy of the dipeptidyl peptidase-4 inhibitor linagliptin in elderly patients with type 2 diabetes: a comprehensive analysis of data from 1331 individuals aged ≥ 65 years. Diabetes, Obesity and Metabolism 16:11, pages 1078-1086.
Crossref
Crossref
Johanna H.M. Driessen, Hein A.W. van Onzenoort, Ronald M.A. Henry, Arief Lalmohamed, Joop P. van den Bergh, Cees Neef, Hubert G.M. Leufkens & Frank de Vries. (2014) Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture. Bone 68, pages 124-130.
Crossref
Crossref
J. Farngren, M. Persson, A. Schweizer, J. E. Foley & B. Ahrén. (2014) Glucagon dynamics during hypoglycaemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetes. Diabetes, Obesity and Metabolism 16:9, pages 812-818.
Crossref
Crossref
Karel Kostev, Franz-Werner Dippel & Wolfgang Rathmann. (2014) Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: A retrospective database analysis. Primary Care Diabetes 8:2, pages 127-131.
Crossref
Crossref
Ramit Ravona-Springer, Anthony Heymann, James Schmeidler, Erin Moshier, James Godbold, Mary Sano, Derek Leroith, Sterling Johnson, Rachel Preiss, Keren Koifman, Hadas Hoffman, Jeremy M. Silverman & Michal Schnaider Beeri. (2014) Trajectories in Glycemic Control over Time Are Associated with Cognitive Performance in Elderly Subjects with Type 2 Diabetes. PLoS ONE 9:6, pages e97384.
Crossref
Crossref
Dominique Simon, Bruno Detournay, Evelyne Eschwege, Stephane Bouée, Jacques Bringer, Claude Attali & Sylvie Dejager. (2014) Use of Vildagliptin in Management of Type 2 Diabetes: Effectiveness, Treatment Persistence and Safety from the 2-Year Real-Life VILDA Study. Diabetes Therapy 5:1, pages 207-224.
Crossref
Crossref
Etie S. Moghissi. (2014) Treating Patients With Diabetes of Long Duration: GLP-1 Receptor Agonists and Insulin in Combination. Journal of Osteopathic Medicine 114:s52, pages 22-29.
Crossref
Crossref
Bo Ahrén. (2013) GLP-1 receptor agonists in the treatment of Type 2 diabetes. Diabetes Management 3:5, pages 401-413.
Crossref
Crossref
Kartik K. Ganju, Hilal Atasoy & Paul A. Pavlou. (2017) 'Where to, Doc?' Electronic Health Record Systems and the Mobility of Chronic Care Patients. SSRN Electronic Journal.
Crossref
Crossref